</ iframe></noscript> <!-- End Google Tag Manager (noscript) --> <div id="page" class="site"><a aria-label="skip to content" class="skip-link" href="#content">Skip to Content</a> <header class="site-header header-layout-three header-layout-seven header-layout-eight" itemscope itemtype="http://schema.org/WPHeader"> <div class="header-holder"> <div class="header-m" style="background-image:url(https://blog.covance.com/wp-content/uploads/2020/04/cropped-dna-blog-header-4.jpg)"> <div class="container"> <div class="site-branding" itemscope itemtype="http://schema.org/Organization"> <p class="site-title" itemprop="name"><a href="https://blog.covance.com/" rel="home" itemprop="url">Insights From Our Labs to Yours</a></p> <p class="site-description" itemprop="description">Covance by LabCorp Blog</p> </div> </div> </div> </div> <div class="sticky-holder"></div> <div class="header-b"> <div class="container"> <button aria-label="primary menu toggle" id="primary-toggle-button"><i class="fa fa-bars"></i>Navigation</button> <nav id="site-navigation" class="main-navigation" itemscope itemtype="http://schema.org/SiteNavigationElement"> <div class="menu-main-container"><ul id="primary-menu" class="menu"><li id="menu-item-6077" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-6077"><a href="https://blog.covance.com">Home</a></li> <li id="menu-item-5821" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5821"><a href="https://blog.covance.com/industry/">Industry</a> <ul class="sub-menu"> <li id="menu-item-5824" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5824"><a href="https://blog.covance.com/industry/device/">Device</a></li> <li id="menu-item-5825" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5825"><a href="https://blog.covance.com/industry/drug-development/">Drug</a></li> <li id="menu-item-5822" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5822"><a href="https://blog.covance.com/industry/chemical/">Chemical</a></li> <li id="menu-item-5823" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5823"><a href="https://blog.covance.com/industry/crop/">Crop</a></li> </ul> </li> <li id="menu-item-5828" class="menu-item menu-item-type-taxonomy menu-item-object-category current-category-ancestor current-menu-ancestor current-menu-parent current-category-parent menu-item-has-children menu-item-5828"><a href="https://blog.covance.com/phase/">Phase</a> <ul class="sub-menu"> <li id="menu-item-5829" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5829"><a href="https://blog.covance.com/phase/discovery/">Discovery</a></li> <li id="menu-item-5835" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5835"><a href="https://blog.covance.com/phase/preclinical-nonclinical/">Preclinical/Nonclinical</a></li> <li id="menu-item-5831" class="menu-item menu-item-type-taxonomy menu-item-object-category current-menu-item menu-item-5831"><a href="https://blog.covance.com/phase/phase-i-iia/" aria-current="page">Phase I-IIa</a></li> <li id="menu-item-5832" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5832"><a href="https://blog.covance.com/phase/phase-iib-iii/">Phase IIb-III</a></li> <li id="menu-item-5833" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5833"><a href="https://blog.covance.com/phase/pilot/">Pilot</a></li> <li id="menu-item-5834" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5834"><a href="https://blog.covance.com/phase/pivotal/">Pivotal</a></li> <li id="menu-item-5830" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5830"><a href="https://blog.covance.com/phase/formulation-packaging/">Formulation, Packaging, etc.</a></li> </ul> </li> <li id="menu-item-5836" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5836"><a href="https://blog.covance.com/molecule-type/">Molecule Type</a> <ul class="sub-menu"> <li id="menu-item-5837" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5837"><a href="https://blog.covance.com/molecule-type/biologics/">Biologics</a></li> <li id="menu-item-5841" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5841"><a href="https://blog.covance.com/molecule-type/small-molecules/">Small Molecules</a></li> <li id="menu-item-5839" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5839"><a href="https://blog.covance.com/molecule-type/biosimilars/">Biosimilars</a></li> <li id="menu-item-5838" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5838"><a href="https://blog.covance.com/molecule-type/biomarkers/">Biomarkers</a></li> <li id="menu-item-5840" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5840"><a href="https://blog.covance.com/molecule-type/cell-gene-therapies/">Cell/Gene Therapies</a></li> </ul> </li> <li id="menu-item-5844" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5844"><a href="https://blog.covance.com/data-informatics/">Data/Informatics</a> <ul class="sub-menu"> <li id="menu-item-5842" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5842"><a href="https://blog.covance.com/data-informatics/send/">SEND</a></li> <li id="menu-item-5845" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5845"><a href="https://blog.covance.com/data-informatics/modeling/">Modeling</a></li> <li id="menu-item-5846" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5846"><a href="https://blog.covance.com/data-informatics/patient-recruitment/">Patient Recruitment</a></li> <li id="menu-item-5843" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5843"><a href="https://blog.covance.com/data-informatics/xcellerate/">Xcellerate</a></li> </ul> </li> <li id="menu-item-5827" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5827"><a href="https://blog.covance.com/about-covance/">About Us</a> <ul class="sub-menu"> <li id="menu-item-5704" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5704"><a href="https://blog.covance.com/about-covance/careers-and-culture/">Careers and Culture</a></li> <li id="menu-item-5792" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5792"><a href="http://response.covance.com/contact-us?elqCampaignId=399&cid=Web_Clk_CVD_blog_megamenunav_0615_399">Contact Us</a></li> <li id="menu-item-5791" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5791"><a href="https://www.covance.com">Covance.com</a></li> </ul> </li> </ul></div> </nav><!-- #site-navigation --> <div class="right"> <div class="tools"> <div class="form-section"> <button aria-label="search form toggle" id="btn-search"><i class="fa fa-search"></i></button> <div class="form-holder"> <form role="search" method="get" class="search-form" action="https://blog.covance.com/"> <label> <span class="screen-reader-text">Search for:</span> <input type="search" class="search-field" placeholder="Search …" value="" name="s" /> </label> <input type="submit" class="search-submit" value="Search" /> </form> </div> </div> </div> <ul class="social-networks"> <li><a href="https://www.linkedin.com/company/covancebylabcorp" target="_blank" rel="nofollow"><i class="fab fa-linkedin"></i></a></li> <li><a href="https://twitter.com/covance" target="_blank" rel="nofollow"><i class="fab fa-twitter-square"></i></a></li> <li><a href="https://www.facebook.com/CovanceByLabcorp" target="_blank" rel="nofollow"><i class="fab fa-facebook"></i></a></li> <li><a href="http://www.youtube.com/user/CovanceMedia" target="_blank" rel="nofollow"><i class="fab fa-youtube"></i></a></li> </ul> </div> </div> </div> </header> <div class="top-bar"> <div class="container"> <header class="page-header"> <h1 class="page-title">Phase I-IIa</h1> </header><!-- .page-header --> <div class="breadcrumb-wrapper"> <div id="crumbs" itemscope itemtype="http://schema.org/BreadcrumbList"> <span itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a itemprop="item" href="https://blog.covance.com"><span itemprop="name">Home</span></a> <meta itemprop="position" content="1" /> <span class="separator">/</span> </span> <span itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"><a itemprop="item" href="https://blog.covance.com/phase/"><span itemprop="name">Phase </span></a><meta itemprop="position" content="2" /><span class="separator">/</span></span> <span class="current" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a itemprop="item" href="https://blog.covance.com/phase/phase-i-iia/"><span itemprop="name">Phase I-IIa</span></a><meta itemprop="position" content="3" /> </span></div></div><!-- .breadcrumb-wrapper --> </div> </div> <div class="container main-content"> <div id="content" class="site-content"> <div class="row"> <div id="primary" class="content-area"> <main id="main" class="site-main"> <div class="row"> <article id="post-7832" class="post-7832 post type-post status-publish format-standard has-post-thumbnail hentry category-cns category-commercialization category-discovery category-drug-development category-phase-i-iia category-phase-iib-iii category-pivotal latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Biomarkes" srcset="https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-1024x683.jpg 1024w, https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-768x512.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers.jpg 1500w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7873" data-permalink="https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/covance-spring-webinars-video-nash-diabetic-heart-biomarkers-2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers.jpg" data-orig-size="1500,1000" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/05/Covance-Spring-Webinars-Video-Nash-Diabetic-Heart-Biomarkers-1024x683.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/&title=Webinar:%20Advancing%20Your%20Neurodegenerative%20Biomarker%20Strategy%20Beyond%20Discovery" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Webinar:%20Advancing%20Your%20Neurodegenerative%20Biomarker%20Strategy%20Beyond%20Discovery https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Webinar:%20Advancing%20Your%20Neurodegenerative%20Biomarker%20Strategy%20Beyond%20Discovery&Body=https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" rel="bookmark">Webinar: Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/05/webinar-advancing-your-neurodegenerative-biomarker-strategy-beyond-discovery/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-08T16:44:50-04:00" itemprop="dateModified">Tuesday, June 8, 2021</time><time class="updated" datetime="2021-05-03T13:59:31-04:00" itemprop="datePublished">Monday, May 3, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>On April 15, we hosted the virtual conference, “Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery.” For study teams working to develop treatments for patients suffering from neurodegenerative diseases, the need to leverage new techniques quickly and effectively is imperative. This topic is vital, as nearly 50 million people worldwide suffer … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7832 --> <article id="post-7803" class="post-7803 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia category-phase-iib-iii category-pivotal tag-kit-production latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/KP2-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="KP2" data-attachment-id="7804" data-permalink="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/kp2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg" data-orig-size="454,606" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2-225x300.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/&title=Expanding%20clinical%20trial%20support%20in%20Europe,%20the%20Middle%20East%20and%20Africa%20with%20a%20new%20automated%20kit%20production%20line" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Expanding%20clinical%20trial%20support%20in%20Europe,%20the%20Middle%20East%20and%20Africa%20with%20a%20new%20automated%20kit%20production%20line https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Expanding%20clinical%20trial%20support%20in%20Europe,%20the%20Middle%20East%20and%20Africa%20with%20a%20new%20automated%20kit%20production%20line&Body=https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" rel="bookmark">Expanding clinical trial support in Europe, the Middle East and Africa with a new automated kit production line</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-08T16:46:20-04:00" itemprop="dateModified">Tuesday, June 8, 2021</time><time class="updated" datetime="2021-03-26T06:00:00-04:00" itemprop="datePublished">Friday, March 26, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>As part of a global growth and expansion strategy, we’re announcing the spring opening of a new kit production line at our European Operations Center (EOC). Based in Mechelen, Belgium, the EOC is a multi-use facility that handles dry ice production and distribution for the EU, as well as study … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7803 --> <article id="post-7799" class="post-7799 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia tag-clinical-pharmacology tag-clinical-trials latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Leeds-Image" data-attachment-id="7800" data-permalink="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/leeds-image-updated-03-15-21-1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1.png" data-orig-size="1287,601" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-300x140.png" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-1024x478.png" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/&title=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK&Body=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark">Covance by Labcorp Announces Plans for New Clinical Pharmacology Site in Leeds, UK</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-03T16:43:19-04:00" itemprop="dateModified">Thursday, June 3, 2021</time><time class="updated" datetime="2021-03-23T09:25:16-04:00" itemprop="datePublished">Tuesday, March 23, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Work is underway to transform an existing building in the heart of Leeds’s Temple district into a fit-for-purpose facility that will raise the bar for clinical conduct and volunteer engagement. The new site will consolidate our two existing central Leeds locations into one facility just minutes away from hospitals and … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7799 --> <article id="post-7756" class="post-7756 post type-post status-publish format-standard has-post-thumbnail hentry category-discovery category-drug-development category-oncology category-phase-i-iia tag-flow-cytometry latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Greenfield3801" srcset="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg 1024w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-768x512.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg 1500w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7760" data-permalink="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/greenfield3801/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg" data-orig-size="1500,1000" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/&title=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation&Body=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark">Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-08T16:46:46-04:00" itemprop="dateModified">Tuesday, June 8, 2021</time><time class="updated" datetime="2021-03-22T16:43:56-04:00" itemprop="datePublished">Monday, March 22, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Despite the development of cellular and antibody-based therapeutics that eliminate malignant cells, patients who have achieved complete remission or response may experience relapse. Increasing evidence suggests that the presence of measurable/minimal residual disease (MRD) in bone marrow (BM) tissue is one, if not the strongest, prognostic factor for disease outcome … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7756 --> <article id="post-7765" class="post-7765 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia category-phase-iib-iii category-xcellerate tag-big-data tag-internet-of-things tag-patient-care-technology tag-xcellerate latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="3-15-2021" srcset="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg 542w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7792" data-permalink="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/3-15-2021-1-04-34-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg" data-orig-size="542,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/&title=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials&Body=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark">Six Automated Clinical Alerts You Need to Increase Efficiency in your Clinical Trials</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/gaylekeenan/">Gayle Keenan, Associate Director, Xcellerate CS</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-03T17:26:07-04:00" itemprop="dateModified">Thursday, June 3, 2021</time><time class="updated" datetime="2021-03-15T14:08:15-04:00" itemprop="datePublished">Monday, March 15, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>What is an automated clinical alert? Automated clinical alerts continuously monitor study data and send alerts and notifications to clinical trial project team members based on specific study, country, site or subject performance criteria to help boost clinical study monitoring and improve quality management.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7765 --> <article id="post-7752" class="post-7752 post type-post status-publish format-standard has-post-thumbnail hentry category-commercialization category-decentralized-clinical-trials category-drug-development category-phase-i-iia category-phase-iib-iii category-pivotal tag-decentralized-clinical-trials-dct latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="DCT2" srcset="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/DCT2-89x60.jpg 89w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7753" data-permalink="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/dct2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg" data-orig-size="537,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-300x202.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/&title=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021 https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021&Body=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark">Decentralized Clinical Trials (DCT) Monthly Blog – February 2021</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/janemyles/">Jane Myles, Director, Covance by Labcorp Decentralized Clinical Trials Implementation</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-03T17:36:35-04:00" itemprop="dateModified">Thursday, June 3, 2021</time><time class="updated" datetime="2021-02-25T17:19:00-05:00" itemprop="datePublished">Thursday, February 25, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Most of our blogs focus on interesting things we hear from sponsors, new company developments, or interesting challenges we encounter as we partner with sponsors. This month, however, we want to take a look at it from the patient perspective. The changes of the past year have resulted in a … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7752 --> <article id="post-7713" class="post-7713 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-oncology category-phase-i-iia category-phase-iib-iii latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="MMM" data-attachment-id="7719" data-permalink="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/1-29-2021-2-36-58-pm-2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg" data-orig-size="803,598" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-300x223.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/&title=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies&Body=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark">Innovation in Plasma Cell Enrichment for Multiple Myeloma Studies</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-03T17:49:26-04:00" itemprop="dateModified">Thursday, June 3, 2021</time><time class="updated" datetime="2021-02-08T07:00:00-05:00" itemprop="datePublished">Monday, February 8, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Syndecan-1 (SDC1), also known as CD138, is a well-known and specific plasma cell marker that is highly expressed on the surface of multiple myeloma plasma cells. As it can be a challenge detecting the small number of malignant plasma cells within the large proportion of cells obtained from a bone … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7713 --> <article id="post-7739" class="post-7739 post type-post status-publish format-standard has-post-thumbnail hentry category-autoimmune-inflammatory category-biologics category-decentralized-clinical-trials category-drug-development category-phase-i-iia category-phase-iib-iii category-small-molecules latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="2-12-2021 12-34-14 PM" srcset="https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM-300x201.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM-90x60.jpg 90w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7740" data-permalink="https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/2-12-2021-12-34-14-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM.jpg" data-orig-size="537,360" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM-300x201.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/02/2-12-2021-12-34-14-PM.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/&title=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20January%202021" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20January%202021 https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20January%202021&Body=https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" rel="bookmark">Decentralized Clinical Trials (DCT) Monthly Blog – January 2021</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/dr-bolaoyegunwa/">Dr. Bola Oyegunwa, VP & Global Head, Covance Decentralized Clinical Trials</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/01/decentralized-clinical-trials-dct-monthly-blog-3/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-04T13:58:48-04:00" itemprop="dateModified">Friday, June 4, 2021</time><time class="updated" datetime="2021-01-27T13:46:00-05:00" itemprop="datePublished">Wednesday, January 27, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>What’s Next? In the aftermath of a turbulent 2020, in which the overall industry perception of the decentralized clinical trial (DCT) approach transitioned from being “promising but still largely experimental” to “a new-normal paradigm for the industry to adopt,” we have been considering “what’s next?”</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7739 --> <article id="post-7684" class="post-7684 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-oncology category-phase-i-iia category-phase-iib-iii latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="TEAM" srcset="https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-300x199.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-768x511.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM.jpg 907w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7685" data-permalink="https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/1-13-2021-1-34-35-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM.jpg" data-orig-size="907,603" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM-300x199.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/01/1-13-2021-1-34-35-PM.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/&title=Centralized%20Multiple%20Myeloma%20Service%20Delivers%20on%20a%20Global%20Scale" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Centralized%20Multiple%20Myeloma%20Service%20Delivers%20on%20a%20Global%20Scale https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Centralized%20Multiple%20Myeloma%20Service%20Delivers%20on%20a%20Global%20Scale&Body=https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" rel="bookmark">Centralized Multiple Myeloma Service Delivers on a Global Scale</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/01/centralized-multiple-myeloma-service-delivers-on-a-global-scale/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-08T16:48:39-04:00" itemprop="dateModified">Tuesday, June 8, 2021</time><time class="updated" datetime="2021-01-25T07:30:00-05:00" itemprop="datePublished">Monday, January 25, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>As the volume of multiple myeloma clinical trials continues to grow, additional tests are being validated in an effort to benefit patients who typically have a five-year survival rate. These dynamics are driving strategies to address variability in testing procedures and data analysis. We recently met with our dedicated Multiple … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7684 --> <article id="post-7665" class="post-7665 post type-post status-publish format-standard has-post-thumbnail hentry category-oncology category-phase-i-iia category-phase-iib-iii latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/01/blogimage-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Multiple Myeloma" data-attachment-id="7667" data-permalink="https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/blogimage-2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/01/blogimage.jpg" data-orig-size="1066,568" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/01/blogimage-300x160.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/01/blogimage-1024x546.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/&title=CRO%20Perspectives:%20Driving%20Innovation,%20Consistency%20and%20Reliability%20in%20Multiple%20Myeloma%20Clinical%20Trials" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=CRO%20Perspectives:%20Driving%20Innovation,%20Consistency%20and%20Reliability%20in%20Multiple%20Myeloma%20Clinical%20Trials https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=CRO%20Perspectives:%20Driving%20Innovation,%20Consistency%20and%20Reliability%20in%20Multiple%20Myeloma%20Clinical%20Trials&Body=https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" rel="bookmark">CRO Perspectives: Driving Innovation, Consistency and Reliability in Multiple Myeloma Clinical Trials</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/01/cro-perspectives-driving-innovation-consistency-and-reliability-in-multiple-myeloma-clinical-trials/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-08T16:48:58-04:00" itemprop="dateModified">Tuesday, June 8, 2021</time><time class="updated" datetime="2021-01-11T06:00:08-05:00" itemprop="datePublished">Monday, January 11, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Despite advances in treatment options, multiple myeloma incidence rates have increased since 1990. Drug development for this complex disease requires a unique combination of technology and expertise. In this short series of blog posts, we will share perspectives on multiple myeloma testing, technique and innovation that can reduce variability and … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7665 --> </div> <div class="pagination"></div> </main><!-- #main --> </div><!-- #primary --> </div><!-- .row/not-found --> </div><!-- #content --> </div><!-- .container/.main-content --> <footer id="colophon" class="site-footer" itemscope itemtype="http://schema.org/WPFooter"> <div class="site-info"> <div class="container"> <span class="copyright">Copyright © 2020 Covance Inc. All rights reserved.</span> </div> </div> </footer><!-- #colophon --> <button aria-label="go to top" id="blossom-top"> <span><i class="fa fa-angle-up"></i>TOP</span> </button> </div><!-- #page --> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/all.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/v4-shims.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/sticky-kit.min.js?ver=1.1.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.min.js?ver=2.2.1'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.aria.min.js?ver=2.0.0'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/jquery.matchHeight.min.js?ver=0.7.2'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/wow.min.js?ver=1.1.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_data = {"lightbox":"","auto":"","loop":"","speed":"3000","animation":"fadeOut","child":"default","sticky":"","sticky_widget":"","header":"eight","url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","rtl":""}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/custom.min.js?ver=2.3.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_ajax = {"url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","startPage":"1","maxPages":"2","nextLink":"https:\/\/blog.covance.com\/phase\/phase-i-iia\/page\/2\/","autoLoad":"load_more","loadmore":"Load More Posts","loading":"Loading...","nomore":"No More Post","layouts":"two-col-right","plugin_url":"https:\/\/blog.covance.com\/wp-content\/plugins"}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/ajax.min.js?ver=2.3.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-includes/js/wp-embed.min.js?ver=5.4'></script> <script type='text/javascript' src='https://stats.wp.com/e-202125.js' async='async' defer='defer'></script> <script type='text/javascript'> _stq = window._stq || []; _stq.push([ 'view', {v:'ext',j:'1:9.1.1',blog:'176650705',post:'0',tz:'-4',srv:'blog.covance.com'} ]); _stq.push([ 'clickTrackerInit', '176650705', '0' ]); </script> <script type="text/javascript"> if(typeof _satellite !== "undefined"){ _satellite.pageBottom(); } </script> </body> </html>